登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《Lancet，5月15日，Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-05-16

  • Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study

    Prof Simon de Lusignan, FRCGP

    Jienchi Dorward, MBChB

    Ana Correa, MPhil

    Nicholas Jones, MSc

    Oluwafunmi Akinyemi, PhD

    Gayatri Amirthalingam, MFPH

    et al.

    Show all authors

    Open AccessPublished:May 15, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30371-6

    Summary

    Background

    There are few primary care studies of the COVID-19 pandemic. We aimed to identify demographic and clinical risk factors for testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within the Oxford Royal College of General Practitioners (RCGP) Research and Surveillance Centre primary care network.

    Methods

    We analysed routinely collected, pseudonymised data for patients in the RCGP Research and Surveillance Centre primary care sentinel network who were tested for SARS-CoV-2 between Jan 28 and April 4, 2020. We used multivariable logistic regression models with multiple imputation to identify risk factors for positive SARS-CoV-2 tests within this surveillance network.

  • 原文来源：https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30371-6/fulltext
3浏览量
原文链接
相关报告

  • 《Nature，11月3日，Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-11-18
    • Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City Daniel Stadlbauer, Jessica Tan, Kaijun Jiang, Matthew M. Hernandez, Shelcie Fabre, Fatima Amanat, Catherine Teo, Guha Asthagiri Arunkumar, Meagan McMahon, Christina Capuano, Kathryn Twyman, Jeffrey Jhang, Michael D. Nowak, Viviana Simon, Emilia Mia Sordillo, Harm van Bakel & Florian Krammer Nature (2020) Abstract In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in China and has since caused a pandemic of Coronavirus Disease 2019 (COVID-19). The first COVID-19 case in New York City (NYC) was officially confirmed on March 1st 2020 followed by a severe local epidemic.1 To understand seroprevalence dynamics, we conducted a retrospective, repeated cross-sectional analysis of anti-SARS-CoV-2 spike antibodies in weekly intervals from the beginning of February to July 2020 using more than 10,000 plasma samples from patients at Mount Sinai Hospital in NYC. Here we show the dynamics of seroprevalence in an ‘urgent care’ (UC) group, enriched for COVID-19 cases during the epidemic, and a ‘routine care’ group (RC), which more closely represents the general population. Seroprevalence increased at different rates in both groups, with seropositive samples as early as mid-February, and levelled out at slightly above 20% in both groups after the epidemic wave subsided by the end of May.
    75浏览量
    原文链接

  • 《JAMA，5月26日，Prevalence of SARS-CoV-2 Among Patients Admitted for Childbirth in Southern Connecticut》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-05-27
    • Prevalence of SARS-CoV-2 Among Patients Admitted for Childbirth in Southern Connecticut Katherine H. Campbell, MD, MPH1; Jean M. Tornatore, MD2; Kirsten E. Lawrence, MD1; et al Jessica L. Illuzzi, MD1; L. Scott Sussman, MD3; Heather S. Lipkind, MD1; Christian M. Pettker, MD1 Author Affiliations Article Information JAMA. Published online May 26, 2020. doi:10.1001/jama.2020.8904 Developing an approach to care for pregnancy and childbirth during the coronavirus disease 2019 (COVID-19) crisis is a priority to (1) provide safe care to pregnant women and newborns; and (2) protect health care workers from infection. A study conducted in New York City reported a 13.5% prevalence of asymptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in women presenting for childbirth.1 On March 30, 2020, an initially asymptomatic woman admitted to the Yale New Haven Health system developed cough and fever soon after childbirth; testing confirmed SARS-CoV-2 infection. This event prompted the development of a SARS-CoV-2 screening and testing program of patients presenting for childbirth; we report the prevalence detected in the first weeks of the program.
    31浏览量
    原文链接